Shopping Cart
- Remove All
- Your shopping cart is currently empty
ET Receptor Antagonist 2 (Compound 16j) is an orally active ET receptor antagonist with an IC50 of 0.22 nM, suitable for pulmonary arterial hypertension (PAH) research. It has been shown to mitigate monocrotaline-induced PAH in a rat model [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | ET Receptor Antagonist 2 (Compound 16j) is an orally active ET receptor antagonist with an IC50 of 0.22 nM, suitable for pulmonary arterial hypertension (PAH) research. It has been shown to mitigate monocrotaline-induced PAH in a rat model [1]. |
In vivo | ET receptor antagonist 2 (compound 16j), administered orally at doses of 150 mg/kg/day and 300 mg/kg/day beginning 48 hours after MCT treatment for a total of 21-26 days, significantly reduced mean pulmonary arterial pressure (mPAP) levels and decreased the levels of HIF1α, ANP, and TNNI3 in rats exposed to MCT. This compound demonstrated antioxidant properties and inhibited lipid peroxidation [1]. |
Molecular Weight | 471.53 |
Formula | C22H25N5O5S |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.